(CNN) — The pharmaceutical company Amgen announced Wednesday that it will decrease the price of its cholesterol lowering drug Repatha by 60%. The company said some patients weren't filling their ...

The pharmaceutical company Amgen announced Wednesday that it will decrease the price of its cholesterol lowering drug Repatha by 60%. The company said some patients weren't filling their prescriptions ...

Most Medicare Part D plans include coverage for Repatha, though specific coverage details can vary among plans. Out-of-pocket costs for Repatha under Medicare Part D typically average around $49 per ...

The pharmaceutical company Amgen announced Wednesday that it will decrease the price of its cholesterol lowering drug Repatha by 60%. The company said some patients weren’t filling their prescriptions ...

Almost all (95%) Medicare drug plans cover Repatha. This includes standalone Part D prescription drug plans and Medicare Advantage plans that include prescription drug coverage. Repatha is a brand ...

NEW YORK, N.Y. (WPVI) -- For people fighting high cholesterol, a new study on the drug Repatha offers good news and bad news. On the up side, 2 years of taking Repatha along with conventional statins ...

The National Institute for Health and Care Excellence (NICE) issued a draft guidance on Wednesday, Nov. 18, turning down Amgen cholesterol drug Repatha as a treatment choice for people with high ...

LONDON (Reuters) - Amgen's new injectable cholesterol drug Repatha has been turned down for use on Britain's state health service, underscoring a worldwide debate about the value of such pricey ...

With the release of the FOURIER trial, Amgen and academic investigators have provided evidence that their novel cholesterol-reducing drug, Repatha (evolcumab), can reduce risk. Among people with ...

Amgen Inc. presented detailed data for the FOURIER cardiovascular outcomes trial of its Repatha (evolocumab) at the American College of Cardiology (ACC) annual meeting, which showed that those ...